Showing 631-640 of 9099 results for "".
Laser Adoption in Dermatology
https://practicaldermatology.com/series/c-suite-chats/laser-adoption-dermatology/26535/Pavel Efremkin, PhD, Founder and CEO of Aerolase, discusses the state of the laser market in dermatology and the various applications of new technology in the field.Considerations for the Use of Biologics in Children with Atopic Dermatitis
https://practicaldermatology.com/series/dermatology-hub-neuroimmune-network/derm-hub/37152/Dawn Zhang Eichenfield, MD, PhD, a dermatologist at Rady Children's Hospital-San Diego and an assistant clinical professor of dermatology at the University of California, San Diego, School of Medicine, explains the most important factors to understand when prescribing biologics for pediatric atopicReal Talk About Residencies
https://practicaldermatology.com/programs/practical-dermatology/program-name/39882/International Federation of Psoriasis Associations (IFPA) executive director Frida Dunger discusses recent awareness efforts, and Practical Dermatology chief medical editor Neal Bhatia, MD, FAAD, is joined by editorial board member Brad P. Glick, DO, MPH, FAAD, for an honest discussion about the staISDPA: Dr. Dy on JAK Inhibitors for Alopecia Areata
https://practicaldermatology.com/conferences/isdpa-midwest-derm-2024/isdpa-dr-dy-jak-inhibitors-alopecia-areata/29150/Lady Dy, MD, talks about the efficacy and safety of JAK inhibitors for treating alopecia areata at the Illinois Society of Dermatology Physician Assistants (ISDPA) Midwest Dermatology Conference 2024.DermWireTV: Diagnosing Melanoma Using Deep-Learning Model; New Adbry Approval
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-diagnosing-melanoma-using-deep-learning-model-new-adbry-approval/26445/In this week's DermWireTV, researchers develop a novel deep-learning model designed to more accurately diagnose melanoma; LEO Pharma receives a new approval for atopic dermatitis drug Adbry; and in our PA Perspectives segment, Andrew Mastro discusses how to build an inflammatory clinic.Clinical Predictors for Distinguishing Transient Pediatric Atopic Dermatitis from Early-onset Atopic March Cases
https://reachmd.com/programs/dermatology-hub-neuroimmune-network/derm-hub/37159/Robert Sidbury, MD, MPH, Chief of Dermatology at Seattle Children’s Hospital and Professor in the University of Washington Department of Pediatrics, talks about clinical predictors for atopic dermatitis vs early-onset atopic march.The Immune System’s Role in Chronic Cases of Atopic Dermatitis
https://reachmd.com/programs/dermatology-hub-neuroimmune-network/derm-hub/37143/Practical Dermatology Chief Medical Editor Neal Bhatia, MD, FAAD, a board-certified dermatologist in San Diego, California, and Director of Clinical Dermatology at Therapeutics Clinical Research, talks about reconciling the roles of Th2, Th22, and Th17 pathways in atopic dermatitis phenotypes, especGaps in Treatment and Approaches for the Pediatric Population with Atopic Dermatitis
https://practicaldermatology.com/series/dermatology-hub-neuroimmune-network/derm-hub/37160/Robert Sidbury, MD, MPH, Chief of Dermatology at Seattle Children’s Hospital and Professor in the University of Washington Department of Pediatrics, describes gaps in treatment for children with atopic dermatitis and reasons for optimism based on ongoing clinical trials.Emerging Insights into the Immunologic Subtypes of Atopic Dermatitis
https://practicaldermatology.com/programs/dermatology-hub-neuroimmune-network/derm-hub/37142/Practical Dermatology Chief Medical Editor Neal Bhatia, MD, FAAD, a board-certified dermatologist in San Diego, California, and Director of Clinical Dermatology at Therapeutics Clinical Research, discusses how new understandings of the immunologic subtypes of atopic dermatitis should influence treatEncouraging Conversation
https://practicaldermatology.com/topics/skin-cancer-photoprotection/encouraging-conversation-40-gep-testing-for-adjuvant-radiation-therapy-candidates/37104/Two studies validate the 40-GEP test for identifying patients most likely to benefit from adjuvant radiation therapy